InvestorsHub Logo
Followers 52
Posts 6517
Boards Moderated 3
Alias Born 01/02/2003

Re: DarthYoda post# 21217

Wednesday, 03/08/2023 6:52:04 PM

Wednesday, March 08, 2023 6:52:04 PM

Post# of 22017
Some good stuff going on in that post. Marcel Bonn-Miller Ph.D. as Chief Scientific Officer seems like a good pick-up based on where he’s been and has done. And part of what he will be doing: In his new role, Dr. Bonn-Miller will lead the Company's R&D portfolio, including new product development, pre-clinical and clinical research, scientific regulatory support, and alternative botanical wellness. He will build upon the Company's existing safety and toxicology data and interface with the FDA's science teams to support regulatory pathways for hemp CBD extracts.
Certainly, sounds like somebody they can use.

Yes, sooner or later they will get that banking squared away, we’ll see what that bill looks like hopefully later this month as they mentioned. The government, FDA, congress, is still holding back a lot growth in this sector, a person can blame certain reasons as to why, but it can’t be held back forever, there will be a dam burst at some point.

The “Quality Standards for Cannabis” was a good read, and the links listed as the bottom opens up into a lot more info , a lot of good information to be learned in all that. It will be highlighted to go back for some more study.

The “Anticancer properties of cannabidiol” is an interesting read, there seems to be more and more studies showing how helpful it is toward fighting cancer, with some study being a possible treatment from even getting it. More time will be needed to sort that out but it is interesting.

At the end of the day there seems to be an awful lot of potential good things with cannabis, too much to ignore or hold back, in fact all those studies should be ramped up. IMO
That was a pretty good post!
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CWBHF News